You wake at seven. Toast — two slices, brown, because brown feels like the responsible choice. Coffee with oat milk, because dairy is complicated and oat milk feels cleaner. Before you leave the kitchen you open the cupboard and take your supplements — the multivitamin, the vitamin D because everyone is apparently deficient, the omega-3 fish oil for your heart and brain, the magnesium because you read it helps with sleep, the iron because your GP mentioned your levels were a little low, the probiotic because gut health matters, the collagen powder stirred into the coffee because your skin has been looking tired, and the ashwagandha because work is relentless and something on Instagram suggested it would help with cortisol. That is eight supplements before eight in the morning. You consider this responsible. You consider yourself, in the language of the wellness world, someone who takes their health seriously.
Out the door by eight-thirty.
Around ten-thirty the hunger arrives — sharp and specific, not a gentle background suggestion but an urgent, insistent instruction from somewhere below conscious thought. You have a cereal bar. The wrapper has a picture of oats and the word "wholesome" and a small leaf that implies, without quite stating, that nature was involved in its production. It takes the edge off. For a while.
Lunch is a meal deal from the supermarket across the road. A sandwich — chicken and bacon, malted bread — a packet of crisps, and a Diet Coke because the regular one feels excessive. Around three o'clock the energy drops again — that familiar early-afternoon collapse that everyone seems to experience and nobody questions — and there are biscuits in the tin someone left in the communal kitchen. Maybe two. You were going to have one.
Dinner is pasta with a jar of tomato and basil sauce because it is Tuesday and Tuesday is not a cooking night. A glass of wine, or a beer afterwards. Maybe two, because the day was long and the beer is cold and you have earned it. You don't smoke. You went to the gym on Monday. You had a salad on Sunday. On balance, by any reasonable assessment of the standards the modern world has given you, you are doing fine.
You are not doing fine.
Not because you made reckless choices. Not because you are careless or ignorant or indifferent to your health — the supplement cabinet alone demonstrates the opposite. But because everything in that day — every meal, every snack, every capsule, every drink — is contributing to a process happening in an organ you have never once thought about, a process that has no symptoms, makes no noise, and will not introduce itself until it is very much further along than you would want it to be.
Your liver has been trying to tell you something for years.
It doesn't know how.
The Organ You Have Never Once Considered
Most people have no relationship with their liver. It does not feature in the daily internal conversation the way the stomach does, or the joints, or the heart when something startles you. It sits in the upper right of your abdomen, tucked beneath the ribcage, roughly the size and weight of a rugby ball, and it goes about its business in complete silence regardless of what you put it through.
That business is extraordinary in its scope. The liver performs somewhere in the region of 600 distinct biological functions — a number so large it becomes almost meaningless until you begin to understand what those functions actually are. It filters everything that enters your bloodstream. Every molecule of food you digest, every drug you take, every alcohol you drink, every supplement capsule you swallow, every chemical you absorb through your skin — every product you chose to apply to your body this morning — passes through the liver first. It decides what is useful, what is toxic, and what needs to be stored, converted, neutralised or expelled.
It regulates your blood sugar, releasing glucose when levels drop and processing the excess when they rise. It manufactures cholesterol — not the dietary cholesterol you have been taught to fear, but the cholesterol your body produces internally, which is the far more consequential part of the equation. It produces bile, without which you cannot digest fat at all. It synthesises proteins essential for blood clotting. It processes and neutralises hormones, determining how long they circulate and at what concentrations. It stores vitamins A, D, E, K and B12, releasing them as the body requires. It is, to use an inadequate analogy, the body's chemical processing plant, its filtration system, its storage facility and its quality control department — simultaneously, without rest, around the clock.
When this organ is compromised, nothing downstream works properly. Not your energy. Not your weight regulation. Not your cholesterol profile. Not your blood sugar. Not your hormones. Not your capacity to think clearly or sleep well or maintain a stable mood. Everything that comes after the liver is dependent on what the liver does first. It is the organ that everything else relies upon — and the vast majority of people spend no time thinking about it whatsoever. Which is, as it turns out, precisely what makes the current situation possible.
A Disease Our Grandparents Did Not Have
Before we explain what is happening in your liver right now, it is worth pausing on a fact that deserves far more attention than it receives — because it dismantles, entirely, the idea that what is happening to you is natural, inevitable, or simply the body ageing as bodies do.
Prior to the processed food era, non-alcoholic fatty liver disease — fatty liver disease in people who do not drink heavily — essentially did not exist as a population-level phenomenon. It was not that medicine lacked the tools to detect it. Autopsy studies from pre-industrial populations show essentially no evidence of the widespread hepatic fat accumulation that we now consider, if not quite normal, then at least unremarkable. The liver diseases that physicians dealt with historically were alcoholic liver disease, from decades of chronic heavy drinking. Viral hepatitis, from contaminated water and food. Genetic conditions like haemochromatosis. Biliary obstruction. These were the liver conditions medicine understood and expected.
A physician in 1950 encountering a patient with a significantly fatty liver and no meaningful alcohol history would have found it unusual enough to write about. Some did. Which is precisely how we know it was unusual.
The term NASH — non-alcoholic steatohepatitis — was coined in 1980 by Ludwig and colleagues at the Mayo Clinic, because they were seeing something they had no existing category for: patients presenting with the liver pathology of a long-term heavy drinker, who reported drinking little or nothing. The broader umbrella term NAFLD — non-alcoholic fatty liver disease — followed as the scale of the phenomenon became clear. It was considered medically curious. A new phenomenon worth documenting. By the late 1980s it was being described in children. By the 1990s the numbers were climbing steeply enough to attract serious research funding. By 2000 it was being described as an emerging epidemic. By 2024 it affects one in four adults across the industrialised world — and is spreading with the pace and trajectory of a Western diet being adopted globally, because that is precisely what it follows. Wherever ultra-processed food goes, the disease follows. It is not a condition of the human body. It is a condition of what is being done to the human body by a specific and identifiable dietary environment.
Your ancestors did not develop this in their thirties from eating. Their livers, in the absence of sustained alcohol use, infectious disease or genetic disorder, functioned without significant metabolic deterioration well into old age. Because that is what the liver is designed to do.
Your liver should function efficiently until the day you die.
That this is no longer a reasonable expectation for a significant and growing proportion of the population, is not a biological mystery. It is a historical event with a traceable cause.
What Is Actually Happening In There
It is called non-alcoholic fatty liver disease — NAFLD — or in the most recent medical literature, MASLD: metabolic dysfunction-associated steatotic liver disease. The name has been updated to reflect a more precise understanding of its mechanisms. The disease has not changed.
It begins when the liver is overwhelmed. Not by alcohol. By fructose — the sugar found in processed food in quantities that bear no relationship to anything the human body encountered across the vast majority of its evolutionary history. By refined carbohydrates that break down to glucose faster than the liver can process them. By the sheer relentless volume of the modern diet, delivered at a pace and frequency and chemical complexity that this organ — however extraordinary — was never designed to handle continuously and without rest.
When the liver cannot process what it receives fast enough, it does what it is biologically programmed to do with excess energy. It converts it to fat through a process called de novo lipogenesis — literally, the creation of new fat — and it stores that fat within its own cells. This is not a malfunction. It is a normal biological response to an abnormal dietary environment. The mechanism is ancient and, in its original context, entirely appropriate. The context it is now operating within is not.
A small amount of fat in the liver cells is within normal parameters — up to around five percent of liver weight is considered acceptable. When fat accumulates beyond that threshold, the disease exists. And in the industrialised world right now, one in four adults exceeds that threshold. It is the most prevalent chronic liver disease across developed nations, advancing into every population that adopts a Western dietary pattern — following the processed food supply across continents with a reliability that leaves very little room for alternative explanations.
Eighty percent of the people who have it do not know.
Where Are You On This Line
Fatty liver does not stay static. It progresses through stages, each one largely indistinguishable from the last without a scan or specific blood markers, the body communicating almost nothing throughout. But the trajectory is consistent, and understanding it matters — because where you sit on this line determines how much time you have, and how much of what has accumulated can still be reversed.
In the earliest stage, fat has accumulated in the liver cells but the tissue is not yet inflamed and the organ is still functioning, after a fashion. It is coping. It is compensating. It is absorbing more than it should and managing, just about, to keep the downstream measurements within ranges that will not immediately concern a GP. This stage is highly reversible. Given the right conditions — and we will come to what those conditions are — a liver at this point will clear the accumulated fat and return to something approaching its intended function. The body is telling you nothing is wrong. The body is mistaken.
In the middle stage, the accumulated fat begins to trigger inflammation. Liver cells are being damaged by the oxidative stress the fat creates, and the immune system responds, sending inflammatory cells to the site. This is the body attempting repair — but the inflammatory response, sustained over time and never given the chance to fully resolve, itself causes damage. Small amounts of scar tissue begin to form as the liver attempts to heal wounds that are not being allowed to close. Reversal is still possible at this stage, but it requires more significant and sustained dietary change. The body is still, largely, telling you nothing is wrong.
As scarring progresses, the liver loses function it cannot fully recover. The scar tissue — fibrosis — begins to replace healthy, functioning liver cells with fibrous material that performs none of the 600 functions the original tissue was handling. At the far end of this progression is cirrhosis: the permanent, structural destruction of the liver's architecture, irreversible, life-limiting, and ultimately fatal without transplant. This is where the heavy drinker's liver ends up after decades of sustained alcohol damage. It is also, increasingly, where the metabolic liver ends up. Without a single drink. Simply from food — and from forty years of a food supply that has been quietly changed around us in ways we were never invited to vote on or even to notice.
Now — here is where something familiar may enter the picture. Because it is typically at the middle stages of this progression that the first external signal surfaces. And it does not announce itself as a liver problem. It arrives as a number. A number on a printed piece of paper from the GP surgery, occasionally underlined, accompanied by a note suggesting your cholesterol is elevated and they would like to discuss it at your next appointment.
Almost every adult over forty has encountered that conversation, or knows someone who has. Most accept it as something that simply happens — an inevitable feature of getting older, like a slower metabolism or a stiff back. Something to manage.
It is not something that simply happens.
Your Cholesterol Is A Liver Story
This is the part of the conversation that almost never occurs in a GP appointment, and it is the part that changes everything about how you understand what is happening in your body.
Your cholesterol is not primarily determined by the cholesterol you eat. This is one of the most significant shifts in nutritional understanding of the last twenty years, and it remains almost entirely absent from public awareness. The liver manufactures the vast majority of the cholesterol circulating in your bloodstream — roughly eighty percent of it. What your liver produces, and in what form, is far more consequential for your cardiovascular health than what you put in your mouth.
A healthy liver produces a balanced lipid profile. It maintains a reasonable ratio of triglycerides — the fat that circulates in the bloodstream after meals — to HDL, the cholesterol that clears lipids from the arterial walls before they can cause damage. It produces LDL cholesterol predominantly in the form of large, buoyant particles that travel through the bloodstream doing the work of transporting fats and fat-soluble nutrients to the cells that need them, without posing significant arterial risk in the process.
A fatty, metabolically stressed liver does none of these things in the same way. It produces triglycerides in excess — flooding the bloodstream with circulating fat that never fully clears because the next meal arrives before the previous one has been processed. It suppresses HDL production, leaving the arterial walls less protected. And critically, it shifts its LDL output away from those large, benign particles toward small, dense LDL — a significantly more dangerous form of the same molecule. Small enough to penetrate arterial walls. More susceptible to oxidation. Far more directly associated with the atherosclerotic plaque formation that precedes cardiovascular events.
The same total LDL reading on your blood test means something entirely different depending on the health of the liver that produced it. A person with a healthy liver producing predominantly large-particle LDL at a reading of 4.5 is in a very different clinical position from a person with a fatty liver producing predominantly small, dense LDL at the same number. The reading is identical. The risk profile is not. Your letter from the surgery almost certainly did not make that distinction.
And it does not stop at cholesterol. A liver under sustained metabolic stress develops insulin resistance — it no longer responds appropriately to insulin's instruction to regulate glucose release, so the pancreas compensates by producing more insulin. More insulin drives more fat storage. More fat storage worsens the liver. The cycle tightens and accelerates. Blood sugar begins to climb. The pathway toward type 2 diabetes — once considered a disease of the elderly and the sedentary — begins here, in the liver, in a person who may be neither.
The systemic inflammation generated by a stressed and inflamed liver does not stay local. It circulates. It contributes to arterial inflammation, to joint inflammation, to the low-grade neurological inflammation increasingly linked to cognitive decline and depression. It disrupts the liver's processing of circulating hormones — oestrogen, testosterone, cortisol — producing imbalances that manifest as fatigue, mood disruption, weight gain that resists intervention, and reproductive dysfunction.
The person sitting in the surgery hearing about their cholesterol is not having a cholesterol conversation. They are having a liver conversation, a metabolic conversation, a cardiovascular conversation, a hormonal conversation and an inflammatory conversation — simultaneously. Nobody has framed it that way. The cholesterol number is the signal. The liver is the source.
The Conveyor Belt
Here is what the cereal bar, the meal deal, the jar of pasta sauce and the biscuits from the communal kitchen tin have in common, beyond their ingredient lists. They were all designed — and engineered is not too strong a word — to ensure that you are hungry again before your body has finished processing what you just consumed.
The mechanism begins with blood glucose. Ultra-processed food is formulated with refined carbohydrates and added sugars that break down in the digestive system almost immediately, flooding the bloodstream with glucose far faster than any whole food could. The pancreas responds with a sharp and aggressive insulin release, proportionate to the size of the spike. The insulin clears the glucose efficiently — but the response is calibrated to the spike, which means blood sugar often drops below its pre-meal baseline as the insulin continues working after the glucose has been cleared. The brain registers this drop as a threat and sends an urgent hunger signal. Not a background awareness that food might be welcome at some point. An insistent, biochemical instruction that is functionally indistinguishable from genuine hunger — arriving sixty to ninety minutes after the last meal.
This is not weakness. This is the body responding correctly to a manufactured chemical stimulus that mimics the signals of genuine nutritional need.
At the same time, the hyper-palatability of processed food — the precisely calibrated combination of salt, sugar, fat and texture that food scientists refer to as the bliss point — interferes with the brain's normal satiety signalling. The neurotransmitter systems that register satisfaction after sufficient food has been eaten are overwhelmed and overstimulated in ways that prevent a clear satiation signal from forming. The brain does not receive a definitive message that enough has been consumed, because the food was specifically formulated to prevent that message from arriving with any clarity. This is not a side effect of the manufacturing process. It is a design objective, refined over decades by food scientists whose professional speciality is manufacturing compulsion — many of whom came directly from the tobacco industry, where manufacturing compulsion was the core business, and applied those skills to food when the cultural and regulatory tide turned against cigarettes in the 1970s and 1980s.
The result is a person eating seven, eight, nine times across a day. Not from greed. Not from a lack of discipline or self-awareness. From a perfectly rational biological response to a dietary environment that was deliberately built to produce exactly that response. And every time they eat, the liver receives another delivery — more fructose to convert to fat, more refined carbohydrate to process, more additives, emulsifiers and industrial seed oils to neutralise — before it has finished working through the last one. The conveyor belt never stops. The liver never rests. Fat accumulates, silently, in cells that have no mechanism to object.
And the supplements being processed alongside everything else? The omega-3 capsule has reasonable clinical evidence behind it and is one of the more defensible items in the cabinet — genuine anti-inflammatory properties and some supporting evidence for liver function in the context of metabolic disease. But the fat-soluble vitamins in the multivitamin — A, D, E, K — are stored in the liver and fatty tissue, and in a liver already overwhelmed by accumulated fat, excess vitamin A in particular can compound the damage rather than address it. The ashwagandha, widely considered a benign adaptogen, now has documented case reports of inducing liver injury in otherwise healthy individuals. The iron supplement, recommended because blood levels came back slightly low, is stored in the liver — and an inflamed liver accumulating excess iron accelerates cellular damage in ways that a standard blood panel, without a dedicated liver function assessment, will not capture. The intention behind every capsule is genuine. The liver processing them alongside everything else on the conveyor belt would like a word.
One Pill Becomes Ten
So the appointment happens. The cholesterol number has come back elevated — perhaps alongside a blood pressure reading that is higher than it should be, or a fasting glucose creeping toward the pre-diabetic range — and the GP, working within a system that allocates approximately seven minutes per patient, does what their training equips them to do. The prescription is written. Statins, most likely, to be taken once a day, indefinitely, because the cholesterol will not manage itself while the liver producing it continues in the same condition, processing the same food.
For a while, the number improves. The statin is working. This is taken as evidence that the problem is being managed.
Eighteen months later, blood pressure has not improved and may have worsened. A second prescription follows — an ACE inhibitor, a beta blocker, a calcium channel antagonist, depending on the clinical picture. Then, at a routine blood test, fasting glucose returns in the pre-diabetic range. Dietary advice is offered — eat less sugar, move more — within the same seven-minute consultation in which two other medications are being reviewed. Six months later the glucose has not improved sufficiently. Metformin is added.
By this point the statins are causing muscle aches — a documented and clinically recognised side effect affecting a significant minority of patients. The dose is adjusted. An alternative statin is tried. The aches persist. Something may be added to manage them, or the patient is advised to continue because the cardiovascular risk of stopping outweighs the discomfort of persisting. The metformin is causing digestive disruption — nausea, bloating, changes in bowel habit — which is managed separately when it is managed at all. A decade after that first cholesterol conversation, a person who walked into a surgery with mildly elevated numbers and no symptoms — who had a bathroom cabinet full of supplements purchased out of genuine health consciousness — is taking eight to ten medications a day.
Each one managing a downstream consequence of a liver that has never once been addressed as the source of any of it. Each one carrying its own side effect profile. Its own interactions with the medications prescribed before and after it. Its own long-term implications for kidney function, gut microbiome integrity, bone density and mitochondrial health. The cumulative pharmacological load on a body already operating under sustained metabolic stress is not an abstraction — it is a compounding biological burden on a system that was already struggling before the first prescription was written.
And through every appointment, every dose adjustment, every repeat prescription — the liver continues processing the same food.
This is not a failure of medicine. It is medicine functioning precisely as it is structured to function. The GP in that appointment is doing exactly what their training equipped them to do. Which raises the question of that training — because it is a question that does not get asked nearly enough.
The average UK medical student, across their five-year degree programme — five years of intensive, demanding, rigorous training in the human body and how to treat its diseases — receives, on average, fewer than four hours of dedicated nutrition education — with studies suggesting the majority receive considerably less. Fewer than four hours. On the subject that underlies the origin of the most common, most costly and most preventable chronic conditions their future patients will spend their lives being medicated for. They are trained comprehensively in pharmacology. In surgical technique. In diagnostic reasoning. In the clinical management of disease across every stage of its progression. They are not trained, in any meaningful sense, in preventing the diseases from developing in the first place.
The GP who wrote your statin prescription is not your adversary. They are a skilled professional operating within a system that was never architected around prevention, in appointments that do not allow for it, armed with a training that did not equip them for it. They are doing precisely what they were taught and precisely what the system incentivises them to do. The question worth sitting with is who designed that system, and why it looks the way it does.
At what point did you decide the food industry was responsible for your health?
And at what point did you decide the medical profession — who you might see for eight minutes, who has been trained for eight hours on nutrition across their five-year degree — was equipped to protect it?
Nobody lied to you directly. Nobody needed to. The system was built this way, incrementally, over decades, by institutions whose structural incentives have never aligned with the long-term metabolic health of the individual sitting in front of them. It has been working exactly as designed.
The Window
Here is the counterweight to everything above, and it deserves to be stated plainly rather than buried in qualification.
The liver, unlike almost any other organ in the human body, retains a remarkable and clinically well-documented capacity for regeneration. It is the only major organ capable of restoring itself from as little as a quarter of its original healthy tissue, given adequate conditions. And in the context of metabolic fatty liver disease — in its early and middle stages, before significant fibrosis has taken hold — the evidence from clinical research is consistent, robust and genuinely encouraging.
Dietary intervention reverses measurable liver fat. Not medication — there is currently no approved pharmacological treatment for NAFLD. Not surgery. Food. Real food, consistently chosen, reduces hepatic fat content in weeks in well-designed clinical trials. The organ that has been silently absorbing the consequences of a food supply reformed around profit rather than nutrition is not passive in its response to being given something different. It responds. It repairs. It wants to recover — and it will recover, if given the conditions to do so.
The window is open. For most people at the early and middle stages of this disease — which is where the majority of the one in four currently sits — the trajectory is not fixed. The damage is not yet permanent. The liver that has been quietly accumulating fat through years of a diet it was never designed to process is the same liver that will begin clearing that fat when the diet changes. It is not too late.
But time matters. Every year of continued metabolic assault moves more people from reversible toward fibrosis. From manageable toward permanent. From a conversation about dietary change toward a conversation about transplant lists. The window is open. For most people reading this, it is still open.
It will not stay open indefinitely.
How Did We Get Here
One in four adults across the industrialised world. Rising, not falling. A disease that was a medical curiosity forty years ago, essentially absent from pre-industrial populations, that maps with uncomfortable precision onto the timeline of ultra-processed food becoming the dominant source of calories in the Western diet — and that follows that diet wherever it spreads.
You did not choose this. Nobody sat down and decided to damage their liver. The question — the one that matters — is how we as a population arrived here simultaneously, without choosing it, without being told. And who made the decisions that brought us here.
That is Part 2.
And the answer is going to make you angry.
References & Sources
- Younossi ZM et al. Global epidemiology of nonalcoholic fatty liver disease: a meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016;64(1):73–84. Global NAFLD/MASLD prevalence estimated at 25.24% across 22 studies. PubMed 26707365
- British Liver Trust. Non-alcoholic fatty liver disease (NAFLD) — patient information. An estimated 80% of those affected are unaware. britishlivertrust.org.uk
- Ludwig J et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc, 1980;55(7):434–8. Coining of the term NASH. PubMed 7382552
- Crowley J et al. Nutrition in medical education: a systematic review. Lancet Planet Health, 2019;3(9):e379–89. Studies consistently find UK medical students receive minimal dedicated nutrition training — surveys indicate over 70% receive fewer than two hours across their entire degree. PMC7664491
- Björnsson ES. Drug-induced liver injury due to herbal and dietary supplements. J Hepatol, 2016;65(6):1232–50. Ashwagandha-induced hepatotoxicity documented in case reports. PubMed 27816895
- UK Soft Drinks Industry Levy (2018) and manufacturer reformulation. Institute for Government. instituteforgovernment.org.uk; Bandy LK et al. The impact of the UK soft drink industry levy on the soft drink marketplace. PLoS One, 2024. PLoS One